PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AQUABEAM Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH). The Company's proprietary AQUABEAM Robotic System delivers Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. Aquablation therapy delivers effective, safe and durable outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH, which are independent of prostate size and shape or surgeon experience.
종목 코드 PRCT
회사 이름Procept Biorobotics Corp
상장일Sep 15, 2021
설립일2021
CEODr. Reza Zadno, Ph.D.
직원 수756
유형Ordinary Share
회계 연도 종료Sep 15
주소150 Baytech Drive
도시SAN JOSE
증권 거래소NASDAQ Global Market Consolidated
국가United States of America
우편 번호95134
전화16502329832
웹사이트https://www.procept-biorobotics.com/
종목 코드 PRCT
상장일Sep 15, 2021
설립일2021
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음